<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01682668</url>
  </required_header>
  <id_info>
    <org_study_id>C11-40</org_study_id>
    <secondary_id>2012-A00225-38</secondary_id>
    <nct_id>NCT01682668</nct_id>
  </id_info>
  <brief_title>Subthalamic Nucleus, Akinesia and Parkinson's Disease</brief_title>
  <acronym>GB-MOV</acronym>
  <official_title>Role of the Subthalamic Nucleus in the Control of Movement: Physiopathology of Akinesia in Parkinson's Disease.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut National de la Santé Et de la Recherche Médicale, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This program aims to understand the role of the subthalamic nucleus in the control of the
      movement in healthy humans and patients with Parkinson's disease, how the STN dysfunction
      contributes to akinesia and how the STN stimulation improves motor signs in PD patients .
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Firing rate of the subthalamic neurons</measure>
    <time_frame>During surgery for bilateral STN stimulation</time_frame>
    <description>Changes in the neuronal activity of the STN before, during and after the execution of an arm movement</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evoked related potentials of the STN</measure>
    <time_frame>3-5 days after surgery for bilateral STN stimulation</time_frame>
    <description>Local-field potentials recordings with DBS electrodes when performing the execution of an arm movement or gait initiation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biomechanical parameters of gait initiation</measure>
    <time_frame>6 months</time_frame>
    <description>Gait initiation parameters by using a forceplate and EMG recordings</description>
  </secondary_outcome>
  <other_outcome>
    <measure>BOLD signal during fMRI</measure>
    <time_frame>1 month before surgery</time_frame>
    <description>Changes in the BOLD signal during fMRI with virtual imagery of movement</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Parkinson's Disease</condition>
  <arm_group>
    <arm_group_label>Frequency of subthalamic stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Comparison between healthy controls and PD patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bilateral subthalamic stimulation</intervention_name>
    <arm_group_label>Frequency of subthalamic stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with Parkinson's disease candidate to DBS surgery

          -  Age: 18-70 years

          -  Normal brain MRI

          -  Signature of the informed written consent

          -  Healthy age-matched control subjects

        Exclusion Criteria:

          -  contraindication to MRI

          -  contraindication to DBS surgery for PD patients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marie-Laure Welter, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>GHPS, APHP, Paris, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marie-Laure Welter, MD, PhD</last_name>
    <email>marie-laure.welter@psl.aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Carine Karachi, MD, PhD</last_name>
    <email>carine.karachi@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CIC-GHPS</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie-Laure WELTER, PH</last_name>
      <phone>0142162461</phone>
      <email>marie_laure.welter@psl.aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier Pitie-Salpêtrière</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie-Laure Welter, MD, PhD</last_name>
      <email>marie-laure.welter@psl.aphp.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 19, 2012</study_first_submitted>
  <study_first_submitted_qc>September 7, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 11, 2012</study_first_posted>
  <last_update_submitted>February 23, 2017</last_update_submitted>
  <last_update_submitted_qc>February 23, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>parkinson's disease</keyword>
  <keyword>subthalamic nucleus</keyword>
  <keyword>akinesia</keyword>
  <keyword>gait initiation</keyword>
  <keyword>neuronal activity</keyword>
  <keyword>before STN stimulation</keyword>
  <keyword>with STN stimulation</keyword>
  <keyword>functional MRI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

